wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38193524-59A4A01A-D715-4AF3-955C-2F9371D505AF
Q38193524-59A4A01A-D715-4AF3-955C-2F9371D505AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193524-59A4A01A-D715-4AF3-955C-2F9371D505AF
Drug safety profile of integrase strand transfer inhibitors.
P2860
Q38193524-59A4A01A-D715-4AF3-955C-2F9371D505AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38193524-59A4A01A-D715-4AF3-955C-2F9371D505AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
11aceceddf909cb7cb5a12dfc64166f145514d1e
P2860
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events